Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation

被引:37
作者
Xiao, Minghan [1 ]
Zhang, Meixia [1 ]
Bie, Mengjun [1 ]
Wang, Xiaowen [1 ]
Guo, Jingwen [1 ]
Xiao, Hua [1 ]
机构
[1] Chongqing Med Univ, Dept Cardiol, Affiliated Hosp 1, 1 Med Coll Rd, Chongqing 400016, Peoples R China
基金
中国国家自然科学基金;
关键词
Atrial fibrosis; Atrial fibrillation; Galectin-3; TGF-beta; 1; CATHETER ABLATION; HEART-FAILURE; MECHANISMS; EXPRESSION; OVEREXPRESSION; FIBROBLASTS; MYOCARDIUM; DISEASE;
D O I
10.1159/000506072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Atrial fibrosis plays a critical role in the occurrence and maintenance of atrial fibrillation. The role of TGF-beta 1 in mediating atrial fibrosis is well documented. The beta-galactoside-binding lectin galectin-3 (Gal-3) is mainly produced by macrophages in biological events such as inflammation and angiogenesis. Previous studies have shown that Gal-3 is associated with atrial fibrosis, but the relationship between TGF-beta 1 and Gal-3 in atrial fibrosis remains unclear.Objective:To determine whether Gal-3 induces atrial fibrosis and atrial fibrillation by activating the TGF-beta 1/Smad pathway and whether the expression of Gal-3 is mediated by TGF-beta 1, which can enable assessing the relationship between Gal-3 and TGF-beta 1 in atrial fibrosis.Methods:In this study, 30 patients' right atrial appendages were collected and divided into 3 groups: congenital heart disease sinus rhythm group (n= 10, as a control group), rheumatic heart disease sinus rhythm group (n= 10), and rheumatic heart disease atrial fibrillation group (n= 10). Rat atrial fibroblasts were cultured in vitro, and recombinant Gal-3 and recombinant TGF-beta 1 proteins were added to the cell culture. The expression of Gal-3, TGF-beta 1, Smad2, and collagen I was detected by Western blotting and quantitative real-time PCR. Atrial tissues were stained with Masson's trichrome stain to evaluate the extent of atrial fibrosis. The expression of Gal-3 and TGF-beta 1 was detected by immunohistochemical staining and immunofluorescence staining. Gal-3 and TGF-beta 1 interaction was demonstrated by immunoprecipitation.Results:The expression levels of Gal-3, TGF-beta 1, Smad2, and collagen I were elevated in the rheumatic heart disease atrial fibrillation group compared with the congenital heart disease sinus rhythm group and the rheumatic heart disease sinus rhythm group. In cultured atrial fibroblasts, there is a synergistic interaction between Gal-3 and TGF-beta 1. Gal-3 stimulated the TGF-beta 1/Smad pathway, and overexpression of TGF-beta 1 induced Gal-3 expression.Conclusions:Gal-3 and TGF-beta 1 interact with each other and stimulate the downstream TGF-beta 1/Smad pathway. This finding suggests that Gal-3 could be an important factor in TGF-beta 1-induced fibrosis in atrial fibrillation. (c) 2020 S. Karger AG, Basel
引用
收藏
页码:446 / 455
页数:10
相关论文
共 46 条
[1]   Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation [J].
Begg, Gordon A. ;
Karim, Rashed ;
Oesterlein, Tobias ;
Graham, Lee N. ;
Hogarth, Andrew J. ;
Page, Stephen P. ;
Pepper, Christopher B. ;
Rhode, Kawal ;
Lip, Gregory Y. H. ;
Holden, Arun V. ;
Plein, Sven ;
Tayebjee, Muzahir H. .
EUROPACE, 2017, 19 (12) :1944-1950
[2]   The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation [J].
Berger, Wouter R. ;
Jagu, Benoit ;
van den Berg, Nicoline W. E. ;
Yin, Dean R. P. P. Chan Pin ;
van Straalen, Jan P. ;
de Boer, Onno J. ;
Driessen, Antoine H. G. ;
Neefs, Jolien ;
Krul, Sebastien P. J. ;
van Boven, WimJan P. ;
van der Wal, Allard C. ;
de Groot, Joris R. .
EUROPACE, 2018, 20 (05) :764-771
[3]   Transforming growth factor-β-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis [J].
Blyszczuk, Przemyslaw ;
Mueller-Edenborn, Bjorn ;
Valenta, Tomas ;
Osto, Elena ;
Stellato, Mara ;
Behnke, Silvia ;
Glatz, Katharina ;
Basler, Konrad ;
Luscher, Thomas F. ;
Distler, Oliver ;
Eriksson, Urs ;
Kania, Gabriela .
EUROPEAN HEART JOURNAL, 2017, 38 (18) :1413-1425
[4]   Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation [J].
Burstein, Brett ;
Nattel, Stanley .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (08) :802-809
[5]   Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure [J].
Clementy, Nicolas ;
Garcia, Bruno ;
Andre, Clementine ;
Bisson, Arnaud ;
Benhenda, Nazih ;
Pierre, Bertrand ;
Bernard, Anne ;
Fauchier, Laurent ;
Piver, Eric ;
Babuty, Dominique .
PLOS ONE, 2018, 13 (08)
[6]   Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation [J].
Clementy, Nicolas ;
Benhenda, Nazih ;
Piver, Eric ;
Pierre, Bertrand ;
Bernard, Anne ;
Fauchier, Laurent ;
Pages, Jean-Christophe ;
Babuty, Dominique .
SCIENTIFIC REPORTS, 2016, 6
[7]   Plasma galectin 3 and heart failure risk in the Physicians' Health Study [J].
Djousse, Luc ;
Matsumoto, Chisa ;
Petrone, Andrew ;
Weir, Natalie L. ;
Tsai, Michael Y. ;
Gaziano, J. Michael .
EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (03) :350-354
[8]   Transforming growth factor (TGF)-β signaling in cardiac remodeling [J].
Dobaczewski, Marcin ;
Chen, Wei ;
Frangogiannis, Nikolaos G. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (04) :600-606
[9]   Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial [J].
Edelmann, Frank ;
Holzendorf, Volker ;
Wachter, Rolf ;
Nolte, Kathleen ;
Schmidt, Albrecht G. ;
Kraigher-Krainer, Elisabeth ;
Duvinage, Andre ;
Unkelbach, Ines ;
Duengen, Hans-Dirk ;
Tschoepe, Carsten ;
Herrmann-Lingen, Christoph ;
Halle, Martin ;
Hasenfuss, Gerd ;
Gelbrich, Goetz ;
Stough, Wendy Gattis ;
Pieske, Burkert M. .
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (02) :214-223
[10]   Macrophages and Galectin 3 Control Bacterial Burden in Acute and Subacute Murine Leptospirosis That Determines Chronic Kidney Fibrosis [J].
Ferrer, Maria F. ;
Scharrig, Emilia ;
Charo, Nancy ;
Ripodas, Ana L. ;
Drut, Ricardo ;
Carrera Silva, Eugenio A. ;
Nagel, Ariel ;
Nally, Jarlath E. ;
Montes de Oca, Daniela P. ;
Schattner, Mirta ;
Gomez, Ricardo M. .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8